Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

– NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE (-) level) by independent review committee – – In four out of five pending patients, MRD negativity in bone marrow ...

There were no roll call votes in the House or Senate last week. This week, Beacon Hill Roll Call reports local ...

Alnylam Canada ULC is pleased to announce that Health Canada has issued a Notice of Compliance (NOC) authorizing AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy in adult patients with ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

High blood pressure (hypertension) can be caused by a variety of factors, including your lifestyle, medical conditions, ...

Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Many conditions, as well as genetics, can cause hair loss and balding. Find out how nutrient deficiencies, hormonal changes, ...

Myalgia often results from muscle strain, injury, or overuse. Chronic conditions like fibromyalgia may require treatment to ease myalgia. Using stress management techniques, like journaling, ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

There were no roll call votes in the House or Senate last week. This week, Beacon Hill Roll Call reports local representatives’ roll call attendance records ...